Brooks Laboratories Ltd
NSE:BROOKS
Brooks Laboratories Ltd
NSE:BROOKS
Price:
98.95 INR
-1.98%
Market Closed
Updated:
May 11, 2024
Section:
Relative Value
The Relative Value of one
BROOKS
stock under the Base Case scenario is
58.74
INR.
Compared to the current market price of 98.95 INR,
Brooks Laboratories Ltd
is
Overvalued by 41%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BROOKS
Relative Value
Base Case
58.74
INR
Overvaluation 41%
Valuation Multiples
Multiples Across Competitors
BROOKS Competitors Multiples
Brooks Laboratories Ltd Competitors
Brooks Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Brooks Laboratories Ltd
NSE:BROOKS
|
2.6B INR | 3.5 | -18.2 | 55.2 | 248.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
229.3B USD | 5.4 | 38.2 | 23.5 | 34.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
187.7B USD | 4.3 | 23.3 | 16.9 | 20.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
43.9B USD | 6.5 | 35.5 | 28.3 | 34.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.5B USD | 2.8 | 31.3 | 16.9 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.9B CHF | 5.6 | 58 | 19.9 | 29.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56T KRW | 15.2 | 65.3 | 34.4 | 49.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.5B USD | 8.6 | 41.2 | 28.5 | 31.7 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.7 | 32.5 | 39.4 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.2 | 17.2 | 26.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.8B USD | 7 | 32.4 | 22.2 | 26.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
